352 related articles for article (PubMed ID: 22579265)
21. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression.
Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811
[TBL] [Abstract][Full Text] [Related]
22. Characterization of epithelial oral dysplasia in non-smokers: First steps towards precision medicine.
Rock LD; Rosin MP; Zhang L; Chan B; Shariati B; Laronde DM
Oral Oncol; 2018 Mar; 78():119-125. PubMed ID: 29496039
[TBL] [Abstract][Full Text] [Related]
23. Smoking and drinking in relation to oral cancer and oral epithelial dysplasia.
Morse DE; Psoter WJ; Cleveland D; Cohen D; Mohit-Tabatabai M; Kosis DL; Eisenberg E
Cancer Causes Control; 2007 Nov; 18(9):919-29. PubMed ID: 17647085
[TBL] [Abstract][Full Text] [Related]
24. Malignant transformation in a cohort of patients with oral epithelial dysplasia.
Hankinson PM; Mohammed-Ali RI; Smith AT; Khurram SA
Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1099-1101. PubMed ID: 34303542
[TBL] [Abstract][Full Text] [Related]
25. Smoking and drinking in relation to oral epithelial dysplasia.
Morse DE; Katz RV; Pendrys DG; Holford TR; Krutchkoff DJ; Eisenberg E; Kosis D; Mayne ST
Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):769-77. PubMed ID: 8896887
[TBL] [Abstract][Full Text] [Related]
26. Clinical, histopathological characteristics and malignant transformation of proliferative verrucous leukoplakia with 36 patients: a retrospective longitudinal study.
Zhang C; Lan Q; Wei P; Gao Y; Zhang J; Hua H
BMC Oral Health; 2024 May; 24(1):639. PubMed ID: 38816724
[TBL] [Abstract][Full Text] [Related]
27. Oral premalignant lesions: from a clinical perspective.
Amagasa T; Yamashiro M; Uzawa N
Int J Clin Oncol; 2011 Feb; 16(1):5-14. PubMed ID: 21225307
[TBL] [Abstract][Full Text] [Related]
28. Risk factors and etiopathogenesis of potentially premalignant oral epithelial lesions.
Porter S; Gueiros LA; Leão JC; Fedele S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):603-611. PubMed ID: 29891084
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Ries J; Agaimy A; Vairaktaris E; Kwon Y; Neukam FW; Strassburg LH; Nkenke E
Int J Oncol; 2012 Sep; 41(3):1085-93. PubMed ID: 22751922
[TBL] [Abstract][Full Text] [Related]
30. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia.
Kaur J; Matta A; Kak I; Srivastava G; Assi J; Leong I; Witterick I; Colgan TJ; Macmillan C; Siu KW; Walfish PG; Ralhan R
Int J Cancer; 2014 Mar; 134(6):1379-88. PubMed ID: 24122701
[TBL] [Abstract][Full Text] [Related]
31. Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression.
Zhang X; Han S; Han HY; Ryu MH; Kim KY; Choi EJ; Cha IH; Kim J
Pathology; 2013 Aug; 45(5):478-83. PubMed ID: 23811806
[TBL] [Abstract][Full Text] [Related]
32. Potentially malignant oral lesions: clinicopathological correlations.
Maia HC; Pinto NA; Pereira Jdos S; de Medeiros AM; da Silveira ÉJ; Miguel MC
Einstein (Sao Paulo); 2016; 14(1):35-40. PubMed ID: 27074232
[TBL] [Abstract][Full Text] [Related]
33. Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: an attempt to understand the sources of variation.
Kujan O; Khattab A; Oliver RJ; Roberts SA; Thakker N; Sloan P
Oral Oncol; 2007 Mar; 43(3):224-31. PubMed ID: 16931119
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic.
Ho MW; Field EA; Field JK; Risk JM; Rajlawat BP; Rogers SN; Steele JC; Triantafyllou A; Woolgar JA; Lowe D; Shaw RJ
Br J Oral Maxillofac Surg; 2013 Oct; 51(7):594-9. PubMed ID: 23601832
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of relationship between risk factors of malignant transformation of oral leukoplakia and the LSCP system].
Sun Z; Gong Y; Huang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Sep; 36(5):364-6. PubMed ID: 11769652
[TBL] [Abstract][Full Text] [Related]
36. [Premalignant disorders and cancer of the oral mucosa].
Reibel J; Holmstrup P
Ugeskr Laeger; 2010 Nov; 172(44):3040-2. PubMed ID: 21044562
[TBL] [Abstract][Full Text] [Related]
37. Molecular pathogenesis of proliferative verrucous leukoplakia: a systematic review.
Okoturo EM; Risk JM; Schache AG; Shaw RJ; Boyd MT
Br J Oral Maxillofac Surg; 2018 Nov; 56(9):780-785. PubMed ID: 30190088
[TBL] [Abstract][Full Text] [Related]
38. Prediction of malignant transformation in oral epithelial dysplasia using infrared absorbance spectra.
Ellis BG; Whitley CA; Triantafyllou A; Gunning PJ; Smith CI; Barrett SD; Gardner P; Shaw RJ; Weightman P; Risk JM
PLoS One; 2022; 17(3):e0266043. PubMed ID: 35333891
[TBL] [Abstract][Full Text] [Related]
39. Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study.
Evren I; Brouns ER; Wils LJ; Poell JB; Peeters CFW; Brakenhoff RH; Bloemena E; de Visscher JGAM
Oral Oncol; 2020 Nov; 110():105014. PubMed ID: 33038723
[TBL] [Abstract][Full Text] [Related]
40. Malignant transformation of oral leukoplakia: a systematic review of observational studies.
Warnakulasuriya S; Ariyawardana A
J Oral Pathol Med; 2016 Mar; 45(3):155-66. PubMed ID: 26189354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
